Volunteers for Liver Study
Recruiting
Study Details
The overall purpose for this study is to find out if the study drug is absorbed or eliminated differently in individuals with normal liver function compared to individuals with impaired liver function. Another purpose is to assess the safety and tolerability of the study drug in individuals with impaired liver function compared to healthy liver function. This study is for research purposes only and is not intended to treat your liver condition.
Method of Administration: Single oral dose
Study Period
• 1 eligibility screening visit
• 11 consecutive days and 10 nights in our research facility
• 4 follow-up visits
Qualified participants will receive study medication, study related physical exams and laboratory tests
Compensation
Compensation Qualified participants will be compensated up to $4,400 for time and travel
Eligibility Criteria
• 18 to 80 years old
• Must have decreased liver function or disease such as fatty liver disease (NASH), Hepatitis C, past history of alcohol related liver disease or cirrhosis
• Volunteers may be taking medicines such as spironolactone (Aldactone®), furosemide (Lasix®), lactulose, or rifaximin (Xifaxan®)
• May also have ascites (fluid in your abdomen) or encephalopathy (brain condition that causes irritability or trouble sleeping)
Research Location:
Share with a Friend
Company Information
Contact Information
Share with a Friend
Other Trials for You
Closed
Featured
BMI: 18-
32
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Closed
BMI: 18-
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Not yet recruiting
Featured
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
Recruiting
Featured
BMI: 65-
85
Volunteer: Healthy
Gender: Man, Woman
Age: 65-
85
Smokers Allowed: No
Recruiting
